Jun Deng
Jun has over a decade of experience in biomedical research and over five years of investment experience in venture capital. she is passionate to help those entrepreneurs use cross-disciplinary approaches to solve issues with broad impact
LinkedIn: http://www.linkedin.com/in/jducla
Silicon Valley
Accredited investor
Member since December 17, 2018
I love new technologies that disrupt traditional areas. In particular, digital health, precision health and diagnostics, AI/AR/VR application in med
- About
Investor interests
| Type of investor | Early stage VC |
| Typical investment size | $50,000 - $100k $100k - $250k $250k - $500k |
| Typical investments in a year | 10 |
| Categories of interest | |
| Locations of interest | |
| Credentials | Accredited Investor |
Activity
| Investments made | noctrix, lark, synthomics, singularity.ai, flux bio, osmosis, Figure8, Wynd, civilmaps, loop genomics, Bioeclipse Therapeutic, Cellsight, TranscribMe! |
| Board seats | Bioeclipse Therapeutic |
Education
| 2009 UCLA , PhD , Molecular Physiology |
I am a(n):
Investor
Full bio
Jun has over a decade of experience in biomedical research and over five years of investment experience in venture capital. Prior to Joyance, Jun led biotech and medtech investment endeavors in venture capital firms. Jun is an entrepreneur herself, and is passionate about education and innovation. At Joyance, she focuses on biotech investment and leads the “lab projects.” Jun enjoys identifying innovative technologists and entrepreneurs and helping them build dreams from scratch. Jun received her PhD from UCLA. She is also a venture partner at Social Starts and an investor at HealthTech Capital.
